Imagene AI, which develops AI-based precision medicine for cancer, announced on Monday that it raised $21.5 million, comprising $3 million in Seed funding led by Blumberg Capital and an $18.5 million Series A round led by renowned technology-driven cancer medicine investors Larry Ellison, Dr. David Agus, and AI imaging space pioneer Eyal Gura.

Read More.